ADB-BUTINACA, a synthetic cannabinoid receptor agonist: overview of its presence in the “Chimique” in Mayotte

dc.contributor.authorAlexandr Gish
dc.contributor.authorAlexandre Peyré
dc.contributor.authorCamille Richeval
dc.contributor.authorEric Pleignet
dc.contributor.authorVictoire Cottereau
dc.contributor.authorJean‐Michel Gaulier
dc.contributor.authorDamien A. Devault
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:52:18Z
dc.date.available2026-03-22T19:52:18Z
dc.date.issued2025
dc.identifier.doi10.1007/s11356-025-37270-x
dc.identifier.urihttps://doi.org/10.1007/s11356-025-37270-x
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78619
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofEnvironmental Science and Pollution Research
dc.sourceCentre Hospitalier Universitaire de Lille
dc.subjectCannabinoid receptor
dc.subjectPharmacology
dc.subjectSynthetic cannabinoids
dc.subjectCannabis
dc.subjectCannabinoid
dc.subjectDrug
dc.subjectPopulation
dc.subjectDrug metabolism
dc.subjectMedicine
dc.subjectBiology
dc.titleADB-BUTINACA, a synthetic cannabinoid receptor agonist: overview of its presence in the “Chimique” in Mayotte
dc.typearticle

Files